Am J Transplant, Volume 20, Suppl 3 Archives - Page 216 of 223 - ATC Abstracts

2020 American Transplant Congress
Concurrent Final Acceptance Associated with Decreased Deceased Donor Liver Utilization
A. Robinson¹, K. Shutterly², M. Sellers³, J. Rosendale¹, D. Brockmeier⁴
¹United Network for Organ Sharing, Richmond, VA, ²Center for Organ Recovery and Education, Pittsburgh, PA, ³Emory University Hospital and LifeLink of Georgia, Atlanta, GA, ⁴Mid-America Transplant Services, St. Louis, MO
*Purpose: With broader sharing for candidates with high MELD scores, it is not unusual for liver candidates to receive offers from multiple donors. Accepting multiple…
2020 American Transplant Congress
Standardized Incidence of De Novo Hematological Malignancies after Liver Transplantation – A Meta-Analysis of Global Transplant Registries
F. Ali¹, S. Soin¹, N. Saleem², P. Myint¹, M. R. Hussain³, B. Ali², A. Khan⁴, S. Nair⁵
¹Saint Joseph Hospital, Chicago, IL, ²UT Health Science Center, Memphis, TN, ³Icahn School of Medicine at Mount Sinai, New York, NY, ⁴West Virginia University, Charleston, WV, ⁵UT Health Science Center, Methodist University Hospital Transplant Institute, Memphis, TN
*Purpose: Liver transplant (LT) recipients are at a higher risk of de novo malignancies. In this study we aim to study the distribution and incidence…
2020 American Transplant Congress
Graft versus Host Disease in Liver Transplant Recipients: A Case Series
N. Joiner, J. Dietz, K. Nava-Estevanott, L. Kerbe
Cleveland Clinic Florida, Weston, FL
*Purpose: Graft Versus Host Disease (GvHD) is a serious and potentially fatal disease that is rarely observed in solid organ transplant recipients; however, we report…
2020 American Transplant Congress
NASH is the Leading Indication for Liver Transplantation in Elderly Patients
J. A. Steggerda¹, J. Yang², V. Sundaaram², N. Alkouri³, W. Ayoub², I. K. Kim¹, M. Noureddin²
¹Surgery, Cedars-Sinai Medical Center, Los Angeles, Los Angeles, CA, ²Hepatology, Cedars-Sinai Medical Center, Los Angeles, Los Angeles, CA, ³Gastroenterology, University of Texas Health- San Antonio, San Antonio, TX
*Purpose: Non-alcoholic steatohepatitis (NASH) is an increasingly prevalent cause of end-stage liver disease (ESLD) and indication for liver transplantation (LT) in the United States and…
2020 American Transplant Congress
Twice Weekly Valganciclovir for Cytomegalovirus Infection Prophylaxis in Kidney Transplant Recipients with Delayed Graft Function on Hemodialysis
S. A. Mehta¹, A. Katz², R. Dieter², P. Jen², J. Siegfried², J. Papadopoulos², T. Lewis²
¹Infectious Diseases, NYU Langone Health, New York, NY, ²Pharmacy, NYU Langone Health, New York, NY
*Purpose: The incidence of cytomegalovirus (CMV) remains high in the first year following kidney transplantation. Valganciclovir (VGC) is commonly prescribed in the early post-operative period…
2020 American Transplant Congress
Does Transplantation of Hepatitis C Infected Kidneys Into Uninfected Recipients Cause Hepatitis C-Associated Kidney Injury?
R. H. Naik, S. Shawar, R. C. Forbes, H. Schaefer, D. Shaffer, M. Rossi, V. Imperio, B. P. Concepcion, M. Kapp
Vanderbilt University Medical Center, Nashville, TN
*Purpose: With increasing utilization of Hepatitis C infected (HCV+) kidneys for transplantation into uninfected (HCV-) recipients, there is concern for the development of HCV-associated kidney…
2020 American Transplant Congress
Preoperative Antibody Titer Against BK Polyomavirus May Predict BK Polyomavirus-Associated Nephropathy after Kidney Transplantation
M. Saito, S. Satoh, K. Numakura, R. Sagehashi, R. Yamamoto, A. Koizumi, T. Nara, S. Narita, T. Habuchi
Urology, Akita University Hospital, Akita, Japan
*Purpose: BK polyomavirus (BKPyV) is a causative agent of BKPyV-associated nephropathy (BKPyV-AN) and hemorrhagic cystitis, which occurs subsequent to BKPyV reactivation. Intravenous immunoglobulin is presumed…
2020 American Transplant Congress
Pharmacist Initiated Hepatitis B Vaccinations in Liver Transplant Recipients
A. Reid¹, S. Todd¹, M. Morrison², A. Adams¹
¹Emory University Hospital, Atlanta, GA, ²Vanderbilt University Medical Center, Nashville, TN
*Purpose: The risk of developing hepatitis B after liver transplantation remains high in nonimmune patients receiving an allograft from a hepatitis B core antibody positive…
2020 American Transplant Congress
Cardiovascular Improvement after Pancreatic Transplantation
S. Y. Suen¹, T. Sparkes¹, R. Kalil², B. Ravichandran¹
¹Pharmacy, University of Maryland Medical Center, Baltimore, MD, ²Nephrology, University of Maryland Medical Center, Baltimore, MD
*Purpose: Cardiovascular disease is a common cause of mortality in patients with uncontrolled diabetes. The purpose of this study is to assess whether patients receiving…
2020 American Transplant Congress
Pig-To-Baboon Liver Xenotransplantation Utilizing Genetically Modified Swine
D. Detelich¹, C. G. Rickert¹, T. M. Coe¹, S. Kimura¹, I. Rosales¹, H. Deng¹, H. Yeh¹, W. Qin², Y. Kan², J. Layer², M. Youd², W. Westlin², L. Yang², J. F. Markmann¹
¹Massachusetts General Hospital, Boston, MA, ²eGenesis, Cambridge, MA
*Purpose: Pig-to-baboon liver xenotransplant (LXT) continues with significant hurdles, including thrombocytopenia, coagulation dysregulation and rejection with the longest reported survival of 29 days utilizing a…